After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
EXEL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Exelixis Inc is $6.88B. A total of 1.77 million shares were traded on the day, compared to an average of 2.25M shares.
In the most recent transaction, Garber Alan M sold 19,205 shares of EXEL for 24.01 per share on Mar 21 ’24. After the transaction, the Director now owns 35,703 company shares. In a previous transaction on Feb 23 ’24, Haley Patrick J. sold 47,020 shares at 21.45 per share. EXEL shares that EVP, Commercial owns now total 384,866.
Among the insiders who bought shares, JOHNSON DAVID EDWARD acquired of 190,000 shares on Feb 21 ’24 at a per-share price of $20.70. This resulted in the Director holding 1,100,730 shares of EXEL after the transaction. In another insider transaction, Haley Patrick J. sold 50,000 shares at $23.35 per share on Dec 14 ’23. Company shares held by the EVP, Commercial now total 307,687.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EXEL has a high of $24.34 and a low of $18.08.
As of this writing, EXEL has an earnings estimate of $Exelixis, Inc. per share for the current quarter. EPS was calculated based on a consensus of Exela Technologies, Inc. estimates, with a high estimate of $Xcel Energy Inc. per share and a lower estimate of $Exelon Corporation.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EXEL’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $51.27M in debt and $337.59M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $2.21B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXEL is Buy with a score of 4.53.
